CAS No 1019206-88-2 REGORAFENIB MONOHYDRATE Pharmaceutical Intermediates
overview
Regorafenib monohydrate is a potent oral multi-kinase inhibitor that plays a vital role in the treatment of various cancers, including colorectal cancer and gastrointestinal stromal tumors (GIST). As a leading pharmaceutical ingredient, it is essential for the formulation of effective cancer therapies.
Our Regorafenib monohydrate is manufactured under strict quality control measures, ensuring that it meets the highest standards required by the pharmaceutical industry.
Physical and Chemical Properties
- Melting point: approximately 150-155°C, indicating stability under standard storage conditions.
- Storage Conditions: Should be stored in a cool, dry place away from light to maintain its integrity and efficacy.
These properties make regorafenib monohydrate an ideal candidate for pharmaceutical formulation, ensuring it remains stable and effective throughout its shelf life.
1. Efficacy in Cancer Treatment: Regorafenib monohydrate is known for its ability to inhibit multiple kinases involved in tumor growth and angiogenesis, making it an important component in cancer treatment.
2. Enhanced bioavailability: The monohydrate form of regorafenib improves its solubility and bioavailability, resulting in better absorption and better therapeutic effect in patients.
3. Customizable formulation: Our regorafenib monohydrate can be easily incorporated into various drug formulations, including tablets, capsules and injections, providing flexibility in product development.
4. Regulatory Compliance: We comply with all relevant regulatory standards, including GMP (Good Manufacturing Practice) and ISO certification, to ensure our products are safe and effective for use in the pharmaceutical industry.
5. Sustainable Development Commitment: As an integrated manufacturing and trading facility, we are committed to sustainable practices to provide high-quality pharmaceutical ingredients while minimizing the impact on the environment.
In conclusion, Regorafenib monohydrate is a high-quality pharmaceutical ingredient that plays a key role in the treatment of various cancers. With its superior physical and chemical properties, enhanced bioavailability, and compliance with industry standards, it is an essential ingredient for pharmaceutical manufacturers seeking to develop effective cancer therapies.
Our commitment to quality, reliability, and sustainability makes us an ideal partner for your pharmaceutical ingredient needs. Choose Regorafenib monohydrate from our integrated facility to provide trusted solutions for your formulations.
For more information or to place an order, contact us today!